University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Self-care behaviors of ovarian cancer patients before their diagnosis: Proof-of-concept study

Flanagan, J.M., Skrobanski, H., Shi, X. and Hirst, Y. (2019) Self-care behaviors of ovarian cancer patients before their diagnosis: Proof-of-concept study Journal of Medical Internet Research, 5 (1), e10447.

Full text not available from this repository.

Abstract

Background: Longer patient intervals can lead to more late-stage cancer diagnoses and higher mortality rates. Individuals may delay presenting to primary care with red flag symptoms and instead turn to the internet to seek information, purchase over-the-counter medication, and change their diet or exercise habits. With advancements in machine learning, there is the potential to explore this complex relationship between a patient’s symptom appraisal and their first consultation at primary care through linkage of existing datasets (eg, health, commercial, and online). Objective: Here, we aimed to explore feasibility and acceptability of symptom appraisal using commercial- and health-data linkages for cancer symptom surveillance. Methods: A proof-of-concept study was developed to assess the general public’s acceptability of commercial- and health-data linkages for cancer symptom surveillance using a qualitative focus group study. We also investigated self-care behaviors of ovarian cancer patients using high-street retailer data, pre- and postdiagnosis. Results: Using a high-street retailer’s data, 1118 purchases—from April 2013 to July 2017—by 11 ovarian cancer patients and one healthy individual were analyzed. There was a unique presence of purchases for pain and indigestion medication prior to cancer diagnosis, which could signal disease in a larger sample. Qualitative findings suggest that the public are willing to consent to commercial- and health-data linkages as long as their data are safeguarded and users of this data are transparent about their purposes. Conclusions: Cancer symptom surveillance using commercial data is feasible and was found to be acceptable. To test efficacy of cancer surveillance using commercial data, larger studies are needed with links to individual electronic health records.

Item Type: Article
Divisions : Faculty of Health and Medical Sciences > School of Health Sciences
Authors :
NameEmailORCID
Flanagan, J.M.
Skrobanski, H.h.skrobanski@surrey.ac.uk
Shi, X.
Hirst, Y.
Date : 17 January 2019
Funders : Cancer Research UK Early Diagnosis Innovation Grant, Cancer Research UK Programme Grant
DOI : 10.2196/10447
Copyright Disclaimer : ©James M Flanagan, Hanna Skrobanski, Xin Shi, Yasemin Hirst. Originally published in JMIR Cancer (http://cancer.jmir.org), 20.12.2018. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on http://cancer.jmir.org/, as well as this copyright and license information must be included.
Uncontrolled Keywords : Acceptability, Cancer, Cancer surveillance, Data linkage, Early diagnosis, Focus group, Proof of concept
Depositing User : Diane Maxfield
Date Deposited : 26 Jun 2019 13:33
Last Modified : 26 Jun 2019 13:38
URI: http://epubs.surrey.ac.uk/id/eprint/852091

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800